Lifestyle Intervention Improves Prothrombotic Coagulation Profile in Individuals at High Risk for Type 2 Diabetes

J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3198-e3207. doi: 10.1210/clinem/dgab124.

Abstract

Context: Patients with obesity and insulin resistance are at higher risk for arterial and venous thrombosis due to a prothrombotic state.

Objective: The present study addressed whether this is reversible by lifestyle intervention and elucidated potential underlying associations.

Methods: A total of 100 individuals with impaired glucose tolerance or impaired fasting plasma glucose participated in a 1-year lifestyle intervention, including precise metabolic phenotyping and MRS-based determination of liver fat content as well as a comprehensive analysis of coagulation parameters before and after this intervention.

Results: During the lifestyle intervention, significant reductions in coagulation factor activities (II, VII, VIII, IX, XI, and XII) were observed. Accordingly, prothrombin time (PT%) and activated partial thromboplastin time (aPTT) were slightly decreased and prolonged, respectively. Moreover, plasminogen activator inhibitor-1 (PAI-1), von Willebrand factor (vWF), and also protein C and protein S decreased. Fibrinogen, antithrombin, D-dimer, and FXIII remained unchanged. Searching for potential regulators, especially weight loss, but also liver fat reduction, improved insulin sensitivity, and decreased low-grade inflammation were linked to favorable changes in hemostasis parameters. Independent of weight loss, liver fat reduction (FII, protein C, protein S, PAI-1, vWF), improved insulin sensitivity (protein S, PAI-1), and reduced low-grade inflammation (PT%, aPTT, FVIII/IX/XI/XII, vWF) were identified as single potential regulators.

Conclusion: Lifestyle intervention is able to improve a prothrombotic state in individuals at high risk for type 2 diabetes. Besides body weight, liver fat content, insulin sensitivity, and systemic low-grade inflammation are potential mechanisms for improvements in hemostasis and could represent future therapeutic targets.

Keywords: fibrinolysis; hemostasis; lifestyle intervention; prediabetes; thrombosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / diagnostic imaging
  • Aged
  • Blood Coagulation / physiology*
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / diagnostic imaging
  • Female
  • Glucose Intolerance / blood*
  • Glucose Intolerance / diagnostic imaging
  • Humans
  • Insulin Resistance / physiology
  • Life Style*
  • Liver / diagnostic imaging
  • Magnetic Resonance Spectroscopy
  • Male
  • Middle Aged
  • Obesity / blood*
  • Obesity / diagnostic imaging
  • Prothrombin Time
  • Thrombosis / blood*
  • Thrombosis / diagnostic imaging